Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2002
12/27/2002CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002CA2446963A1 Quinazolinediones as antibacterial agents
12/27/2002CA2439060A1 Emissive multichromophoric systems
12/26/2002US20020198380 Reacting tetrachloropyrimido(5,4-d)pyrimidine with amine compound; reducing to form 4,6-diaminopyrimido(5,4-d)pyrimidine compound
12/26/2002US20020198379 Active compound from a sponge
12/26/2002US20020198377 For improving perception, concentration power, learning power and/ or memory power
12/26/2002US20020198232 4-substituted quinoline derivatives
12/26/2002US20020198223 Pharmaceutically active compounds
12/26/2002US20020198222 Use of triazolopyrimidine derivatives as microbicides
12/26/2002US20020198221 For use as sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent
12/26/2002US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/26/2002US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002US20020198196 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
12/26/2002US20020198191 Cyclohexylphenyl vasopressin agonists
12/26/2002US20020198190 Tetracyclic 1,2,3,4,5,6- hexahydroazepino-(4,5-b)indole derivatives having a ring connecting position 6 (N-6) and position 7 (C-7); treating or preventing a disease or disorder of the central nervous system in a mammal
12/25/2002CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/24/2002US6498251 Tetrahydrobenzindole derivatives
12/24/2002US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis
12/24/2002US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/24/2002US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002CA2131019C Nitrosation process
12/19/2002WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002WO2002100864A1 Pyrazolopyrazine compound and pharmaceutical use thereof
12/19/2002WO2002100863A1 Corticotropin releasing factor antagonists
12/19/2002WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
12/19/2002WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002WO2002100828A2 Process for the production of zaleplon
12/19/2002WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002WO2002100354A2 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/19/2002WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002WO2002062797A3 Pharmaceutical uses and synthesis of diketopiperazines
12/19/2002WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002WO2000058303A9 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
12/19/2002US20020193608 For preparing and using libraries of compounds as well as individual compounds of the libraries; for screening compounds for combinatorial chemistry
12/19/2002US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002US20020193595 Agonists of the melanocortin-4 receptor ("MC-4r"); useful treating obesity and type 2 diabetes
12/19/2002US20020193399 N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors
12/19/2002US20020193388 Pharmaceutically active compounds
12/19/2002US20020193385 Imidazo-pyrimidine derivatives as ligands for gaba receptors
12/19/2002US20020193378 Usable as tranquillisers and hypnotics
12/19/2002US20020193376 Administering compounds containing fused, 6-, 5-membered bicyclic heteroaromatic rings containing nitrogen as one of the two bridging atoms for decreasing intraocular pressure in an animals including humans
12/19/2002US20020193364 For therapy of central nervous system (CNS) diseases
12/19/2002US20020193239 For use as catalysts in epoxidation of olefins, for oxidation of alcohols, oxidation of organic thiols; hydroxylation of aromatic compounds; ammoximation of ketones
12/19/2002CA2450384A1 Process for the production of zaleplon
12/19/2002CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002EP1266899A2 Rapamycin hdroxyesters, process for their preparation and pharmaceutical compositions containing them
12/18/2002EP1265901A2 Process for the preparation of midazolam
12/18/2002EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002EP1265897A1 Non-amidine containing protease inhibitors
12/18/2002EP0725783B1 2-(pyrazol-3-yl)carbapenem derivatives
12/18/2002CN1385430A Treatment for mother liquid obtained in preparation of high-purity triethylenediamine
12/18/2002CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine
12/18/2002CN1096461C Purine derivatives and their use as anti-coagulants
12/17/2002US6495700 Process for producing phenserine and its analog
12/17/2002US6495699 Antiarthritic agents; osteoporosis
12/17/2002US6495688 Used as corticotropin-releasing factor (crf) antagonists, in therapy and diagnosis of stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety
12/17/2002US6495686 Therapy for psychological disorders
12/17/2002US6495559 For therapy of obesity
12/17/2002US6495543 Treating or preventing melatoninergic disorders
12/17/2002US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/17/2002US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/17/2002CA2203389C Bicyclic heterocyclic compounds for the treatment of impotence
12/12/2002WO2002098956A1 Monomers having rotaxane structure and polymers and processes for production of both
12/12/2002WO2002098882A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
12/12/2002WO2002098881A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
12/12/2002WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002WO2002098879A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
12/12/2002WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002WO2002098868A1 Epothilone derivatives
12/12/2002WO2002098855A2 1,2,4-TRIAZOLO[4,3-a][1,3,5]TRIAZINE-3,5,7-SUBSTITUTED PRECURSOR, AND PROCESS, AND COMPOUNDS THEREFROM
12/12/2002WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002WO2002098417A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
12/12/2002WO2002098350A2 Pyranoindazoles and their use for the treatment of glaucoma
12/12/2002WO2002068389A3 Indole derivatives with inhibitor effects on phenol oxidase
12/12/2002WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002US20020188136 Pesticides and herbicides
12/12/2002US20020188119 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
12/12/2002US20020188111 For photodynamic therapy of a lesion; medical diagnosis; drug screening; bioavailability
12/12/2002US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002US20020187984 Pharmaceutical uses and synthesis of diketopiperazines
12/12/2002US20020187977 Methods for restoring cognitive function following systemic stress
12/12/2002US20020187101 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
12/12/2002CA2449877A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
12/12/2002CA2449316A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
12/12/2002CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002CA2449095A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002CA2449077A1 Epothilone derivatives
12/12/2002CA2447480A1 Pyranoindazoles and their use for the treatment of glaucoma
12/11/2002EP1264836A1 Processes for the preparation of indolopyrrolocarbazole derivatives
12/11/2002EP1263761A2 Compounds for pdt
12/11/2002EP1263759A2 Azaindoles